U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07239570) titled 'A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease' on April 30.
Brief Summary: Over 800 million people worldwide suffer from chronic kidney disease (CKD), which is associated with a high individual disease burden for those affected, multiple secondary diseases, frequent doctor contacts, and hospitalizations, but also outstanding costs for the health system and the solidarity community. Appropriate interventions are essential to prevent the development and progression of CKD. In the past decade, great progress has been made in the search for drugs that can slow the progression of CKD. ...